{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:40:48Z","timestamp":1789666848958,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":5575,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1046\/j.1523-1755.2000.00277.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:36:39Z","timestamp":1047461799000},"page":"1219-1227","source":"Crossref","is-referenced-by-count":188,"title":["Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo"],"prefix":"10.1016","volume":"58","author":[{"given":"Nancy J.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Donnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes B.","family":"Fogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(84)90882-9","article-title":"Glomerular actions of angiotensin II","volume":"76","author":"Ichikawa","year":"1984","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0015","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.HYP.19.5.464","article-title":"Renal injury from angiotensin II-mediated hypertension","volume":"19","author":"Johnson","year":"1992","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/ki.1994.69","article-title":"Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms","volume":"45","author":"Tanaka","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ki.1995.15","article-title":"Internephron heterogeneity of growth factors and sclerosis-modulation of platelet derived growth factor by angiotensin II","volume":"47","author":"Tanaka","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0035","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.HYP.13.6.706","article-title":"Angiotensin II induces c-fos expression in smooth muscle via transcriptional control","volume":"13","author":"Naftilan","year":"1989","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0040","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI117251","article-title":"Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells","volume":"93","author":"Kagami","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0045","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/ki.1994.215","article-title":"Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney","volume":"45","author":"Kaneto","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1172\/JCI104261","article-title":"The effects of intravenous infusions of valine-5 angiotensin II and other pressor agents on urinary electrolytes and corticoids including aldosterone","volume":"60","author":"Biron","year":"1961","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0055","series-title":"Hypertension: Pathophysiology, Diagnosis, and Management","first-page":"1287","article-title":"The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis,","author":"Sealey","year":"1990"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0060","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.24.1.30","article-title":"Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension","volume":"24","author":"Robert","year":"1994","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0070","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0085","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.ATV.17.6.1152","article-title":"Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats","volume":"17","author":"Benetos","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.cb.04.110188.000521","article-title":"Cell-associated plasminogen activation: Regulation and physiologic functions","volume":"4","author":"Saksela","year":"1988","journal-title":"Annu Rev Cell Biol"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0095","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0955-0674(89)90068-9","article-title":"Proteinases and extracellular matrix remodeling","volume":"1","author":"Alexander","year":"1989","journal-title":"Curr Opin Cell Biol"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0100","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI115405","article-title":"The plasminogen activator\/plasmin system","volume":"88","author":"Vassalli","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI118396","article-title":"Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene","volume":"97","author":"Eitzman","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0110","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI117809","article-title":"Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells","volume":"95","author":"Vaughan","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/01.CIR.90.1.362","article-title":"Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells","volume":"90","author":"van Leeuwen","year":"1994","journal-title":"Circulation"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0120","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ki.1997.96","article-title":"Dual effects of angiotensin II on the plasminogen\/plasmin system in rat mesangial cells","volume":"51","author":"Kagami","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0125","first-page":"336","article-title":"Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production","volume":"85","author":"Brown","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.HYP.32.6.965","article-title":"Effect of activation and inhibition of the renin angiotensin system on plasma PAI-1 in humans","volume":"32","author":"Brown","year":"1998","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0135","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1073\/pnas.89.15.6998","article-title":"Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries","volume":"89","author":"Schneiderman","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1056\/NEJM199209103271102","article-title":"Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome","volume":"327","author":"Bergstein","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0145","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ki.1995.435","article-title":"Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis","volume":"48","author":"Moll","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ki.1997.20","article-title":"Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition","volume":"51","author":"Oikawa","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2307\/3576671","article-title":"Vascular permeability and late radiation fibrosis in mouse lung","volume":"103","author":"Law","year":"1985","journal-title":"Radiat Res"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2307\/3578243","article-title":"Treatment of radiation nephropathy with captopril","volume":"132","author":"Cohen","year":"1992","journal-title":"Radiat Res"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0165","first-page":"650","article-title":"Three new epoxy-spirolactone derivatives: Characterization in vivo and in vitro","volume":"240","author":"Degasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0175","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/01.CIR.93.6.1073","article-title":"Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta","volume":"93","author":"Hamdan","year":"1996","journal-title":"Circulation"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/01.HYP.15.3.327","article-title":"Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit","volume":"15","author":"Chobanian","year":"1990","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0185","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.184.4140.994","article-title":"Angiotensin II- and angiotensin III-induced aldosterone release in vivo in the rat","volume":"184","author":"Campbell","year":"1974","journal-title":"Science"},{"key":"10.1046\/j.1523-1755.2000.00277.x_bb0190","first-page":"2797","article-title":"Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin","volume":"81","author":"Takeda","year":"1996","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815472114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815472114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T21:08:05Z","timestamp":1635541685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815472114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0085253815472114"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00277.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}